Julie M. Fleshman, JD, MBA,

PanCAN President and CEO, leading the way for more than two decades in PanCAN’s approach to take bold steps to make progress in pancreatic cancer research and improve patient outcomes

Anne-Marie Duliege, MD

PanCAN Chief Medical Officer, responsible for the strategic direction and operational oversight of the organization’s clinical initiatives, including PanCAN’s Precision Promise℠ clinical trial. Expertise in Hematology, Immunology, Nephrology & Infectious Diseases

Nipun Merchant, MD

PanCAN Scientific and Medical Advisory Board Member, Vice Chair of Surgical Oncology Services, Chief of the Division of Surgical Oncology in the Department of Surgery, Chief Surgical Officer, Associate Director of Translational Research (Interim) at Sylvester Comprehensive Cancer Center, University of Miami

Eileen O'Reilly, MD

PanCAN Scientific and Medical Advisory Board Member, PanCAN’s Precision Promise Site Principal Investigator, Associate Director Clinical Research at David M. Rubenstein Center for Pancreatic Cancer, Memorial Sloan-Kettering Cancer Center